Clinical Outcomes And Mortality In Old And Very Old Patients Undergoing Cardiac Resynchronization Therapy

AimCardiac resynchronization therapy (CRT) is a valid therapeutic option for patients with heart failure (HF). However, the elderly population was not well represented in the guidelines. The primary end point was to evaluate the impact of advanced age on clinical response and cardiovascular and total mortality of patients undergoing CRT. The secondary end point was to assess the rate of acute complications related to the procedure.Methods and resultsA total of 249 consecutive patients with HF and optimized treatment, QRS >= 120 ms, ejection fraction (EF) <= 35% and functional class (FC) III/IV (NYHA) underwent CRT and divided into 3 groups: Group I-< 65 years-88/249 (35%); Group II-65 to 75 years (old)72/ 249 (29%); Group III->= 75 years (very old)-89/249 (36%). The improvement in FC and increase in EF (> 10%) and/or decrease in the left ventricular end systolic diameter (LVESD) > 15% were the criteria of responsiveness. The favorable clinical response (p = ns) and cardiovascular mortality (p = 0.737) was similar in the 3 groups. In the group of very old patients, a significant increase in total mortality was observed (p = 0.03). The rate of acute complications related to the procedure did not differ between the groups (p = ns).ConclusionThe response to CRT and cardiovascular mortality were not affected by the advanced age and should not be an exclusion factor of this therapy. The procedure has been shown to be safe in elderly patients due to low rate of acute complications.